Epiminder Ltd (epi) Logo

Epiminder Ltd (EPI)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

EPI ASX Chart

Snapshot

Epiminder Limited (EPI) is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Headquartered in Melbourne, Australia, the Company also has a presence in Sydney, Australia and in the US.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -74.68%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,167 of 2,339
Sector Rank 87 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies -
EPS $0.00
DPS $0.00
Book Value Per Share $462.773

Broker Consensus

EPI is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website epiminder.com
Registry BoardRoom
Auditor MVAB ASSURANCE
Date Listed 1 Dec 2025

Upcoming Calendar (Forecasted)

Date Event
24/02/2027 Report (Interim)

Former Company Names

  • Epiminder Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

EPI directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
15/05/26 Robert Klupacs Buy +10,000 $0.469 $4,690 On-market trade
15/05/26 Jeffrey Sells Buy +45,475 $0.455 $20,691 On-market trade
14/05/26 Donal O'Dwyer Buy +21,500 $0.46 $9,890 On-market trade
14/05/26 Patricia ORourke Buy +11,350 $0.45 $5,107 On-market trade
16/03/26 Philip Binns Buy +7,352 $0.635 $4,668 On-market trade
27/02/26 Robert Klupacs Buy +7,500 $0.85 $6,375 On-market trade
08/12/25 Patricia ORourke Buy +10,000 $1.11 $11,074 On-market trade
08/12/25 Donal O'Dwyer Buy +33,334 $1.08 $35,893 On-market trade
08/12/25 Jeffrey Sells Buy +22,525 $1.08 $24,252 On-market trade
05/12/25 Robert Klupacs Buy +10,000 $1.00 $10,049 On-market trade
04/12/25 Robert Klupacs Buy +10,000 $1.08 $10,789 On-market trade

Director Interests

The current holdings of EPI directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Robert Klupacs 15/05/2026 565,121 N/A N/A N/A
Jeffrey Sells 15/05/2026 N/A 118,000 N/A N/A
Patricia ORourke 14/05/2026 N/A 571,332 N/A N/A
Donal O'Dwyer 14/05/2026 N/A 283,561 N/A N/A
Philip Binns 16/03/2026 N/A 1,068,498 1,539,776 N/A
Rohan Hoare 07/12/2022 33,333 N/A 6,726,088 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Nov 27, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Cochlear Investments Pty Ltd 77,982,069 35.99%
The Bionics Institute Of Australia 15,773,644 7.28%
J P Morgan Nominees Australia Pty Limited 12,642,848 5.83%
Citicorp Nominees Pty Limited 8,661,912 4.00%
BNP Paribas Noms Pty Ltd 8,432,804 3.89%
St Vincents Hospital (Melbourne) 7,821,432 3.61%
UMC Commercialisation Pty Ltd <Umc Commercialisation A/C> 7,543,140 3.48%
UBS Nominees Pty Ltd 6,507,399 3.00%
Argo Investments Limited 5,999,999 2.77%
Olabella Pty Ltd 5,179,264 2.39%
HSBC Custody Nominees (Australia) Limited 5,156,285 2.38%
HSBC Custody Nominees (Australia) Limited - A/C 2 3,961,027 1.83%
Michael Andrew Murphy & Michelle Maree Murphy <Murphy Family S/F A/C> 3,138,000 1.45%
Seer Medical Pty Ltd 2,652,964 1.22%
The Nigel Ashton Family Pty Ltd 1,695,362 0.78%
Mirrabooka Investments Limited 1,666,666 0.77%
Real Good Pty Ltd 1,349,320 0.62%
Rubino Group Pty Ltd <Rubino Group A/C> 1,330,000 0.61%
Anne Shireen Cook <Cook Family Investment A/C> 1,244,465 0.57%
BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 1,082,463 0.50%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 9 236 176 562 81 1,064

Substantial Shareholders

No Substantial Shareholders for EPI in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
01-12-25 Cochlear Investments Pty Ltd 110,289,228 -- 50.90
01-12-25 The Bionics Institute of Australia 15,773,644 -- 7.30

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
EPI Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.